全球静脉输液泵市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

预计到2030年，全球静脉输液泵市场需求将从2022年的85.2亿美元增至188.3亿美元，2023-2030年的复合年增长率为10.42%。

静脉输液泵是一种医疗设备，用于通过静脉将液体、药物和营养物质直接输送到患者的血液中。这些设备通常用于医院、诊所和其他医疗机构，在设定的时间内输送精确、可控量的液体或药物。静脉输液泵旨在精确控制液体或药物进入患者血液的流速。它们通常由一个泵装置、一个液体或药物储存器以及一个通过静脉导管连接到患者静脉的输液系统组成。这些泵可以通过编程在设定的时间内输送特定容量的液体或药物，从而实现精确的剂量和输送。它们通常用于静脉注射抗生素、化疗药物和其他需要控制和精确给药的药物。静脉输液泵还可能具有其它功能，如检测管道中的气泡或同时输送多种药物。有些型号还可以是便携式或可穿戴式的，使患者可以在家中或外出时接受治疗。

市场动态：

随着全球人口老龄化以及癌症、糖尿病和心血管疾病等慢性病发病率的不断上升，预计对静脉输液泵的需求将增加。这些泵通常用于向慢性病患者输送药物和液体，随着慢性病患者人数的增加，对输液泵的需求也将增加。新型和创新的静脉输液泵更加精确、可靠和方便用户使用。这些泵通常包括无线连接、触摸屏界面、自动监测和警报等功能，使其更易于使用，并提高了患者安全性。随着医疗成本的持续上升和医院寻求降低再入院率的方法，对家庭医疗保健服务的需求日益增长。静脉输液泵是许多家庭医疗保健治疗的重要组成部分，因为患者可以在家中接受药物治疗和输液，而无需前往医院或诊所。全球外科手术数量不断增加，推动了对静脉输液泵的需求。这些泵通常在手术过程中用于输送麻醉药和其它药物，随着手术数量的增加，对输液泵的需求也将增加。在许多国家，医疗系统为使用静脉输液泵提供报销，这有助于推动对这些设备的需求。报销政策因国家和输液泵类型而异，但总体而言，有利的政策有望促进市场增长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构，评估全球竞争吸引力。此外，这些工具还对全球静脉输液泵市场的各个细分市场进行了全面评估。静脉输液泵行业的增长和趋势为本研究提供了整体方法。

市场细分：

静脉输液泵市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

• 容积式输液泵
• 胰岛素输注泵
• 注射器输注泵
• 肠内输注泵
• 非卧床输注泵
• 患者控制镇痛（PCA）
• 植入式输注泵
• 其他

按疾病分类

• 化疗
• 糖尿病
• 胃肠病学
• 镇痛/疼痛管理
• 儿科/新生儿科
• 血液科
• 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美、中东和非洲地区静脉输液泵市场的当前和未来需求。此外，报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。静脉输液泵市场的主要参与者包括百特国际公司、博朗梅尔松根公司、美敦力公司、麦瑞医疗设备公司、波士顿科学公司、CareFusion公司、费森尤斯卡比公司、史密斯医疗公司、霍夫曼拉罗氏公司、Tandem糖尿病护理公司、泰尔茂公司、Mindray公司、穆格公司、IRadimed公司。本部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

目 录

第一章：前言

• 报告描述
  • 报告目标
  • 目标受众
  • 独特销售主张（USP）和产品
• 研究范围
• 研究方法
  • 市场调研流程
  • 市场调研方法

第二章：执行摘要

• 市场亮点
• 全球市场概况

第三章：静脉输液泵-行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制因素
• 市场机会
• 行业趋势
• 波特五力分析
• 市场吸引力分析
  • 按产品分类的市场吸引力分析
  • 按疾病适应症的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原材料制造商列表
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直接营销
  • 间接营销
  • 营销渠道发展趋势

第五章：COVID-19疫情影响分析

第六章：全球静脉输液泵市场分析：按产品分类

• 产品概述
• 历史和预测数据
• 按产品分析
• 容积式输注泵
• 胰岛素输注泵
• 注射器输注泵
• 肠内输注泵
• 非卧床输注泵
• 患者控制镇痛（PCA）
• 植入式输注泵
• 其他输液泵

第七章 ：全球静脉输液泵市场分析：按疾病适应症分类

• 疾病适应症概述
• 历史和预测数据
• 按疾病适应症分析
• 化疗
• 糖尿病
• 胃肠病学
• 镇痛/疼痛管理
• 儿科/新生儿科
• 血液科
• 其他

第八章：全球静脉输液泵市场分析：按地区划分

• 地区展望
• 区域概况
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美细分市场销售分析
  • 北美地区各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区各细分市场销售分析
  • 亚太地区各国销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲各细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东及非洲其他地区销售分析

第九章 : 静脉输液泵企业竞争格局

• 静脉输液泵市场竞争格局
• 伙伴关系/合作/协议
• 合并与收购
• 新产品上市
• 其他发展

第10章 : 公司简介

• 顶级公司市场份额分析
• 市场集中度
• Baxter International
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• B. Braun Melsungen AG
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Medtronic
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Micrel Medical Devices SA
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Boston Scientific Corporation
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• CareFusion Corporation
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Fresenius Kabi
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Smiths Medical
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• F. Hoffmann-La Roche Ltd.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Tandem Diabetes Care Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Terumo Corporation
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Mindray
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Moog Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• IRadimed Corporation
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展

*注：在公司概况中，财务细节和近期发展取决于可用性，如果是私营公司，则可能不包括在内。

The global demand for Intravenous Infusion Pump Market is presumed to reach the market size of nearly USD 18.83 BN by 2030 from USD 8.52 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.

An intravenous infusion pump is a medical device used to deliver fluids, medications, and nutrients directly into a patient's bloodstream through a vein. These devices are typically used in hospitals, clinics, and other healthcare settings to deliver a precise and controlled amount of fluids or medications over a set period of time. Intravenous infusion pumps are designed to accurately control the flow rate of fluids or medications into the patient's bloodstream. They typically consist of a pump mechanism, a reservoir for the fluid or medication, and a delivery system that is connected to the patient's vein through an intravenous catheter. These pumps can be programmed to deliver a specific volume of fluid or medication over a set period of time, allowing for precise dosing and delivery. They are commonly used to administer intravenous antibiotics, chemotherapy drugs, and other medications that require a controlled and precise delivery. Intravenous infusion pumps may also have additional features, such as the ability to detect air bubbles in the tubing or to deliver multiple medications simultaneously. Some models may also be portable or wearable, allowing patients to receive treatment at home or while on the go.

Market Dynamics:

As the global population ages and the incidence of diseases which are chronic in nature, such as cancer, diabetes, and cardiovascular disease, continues to rise, the demand for intravenous infusion pumps is expected to increase. These pumps are commonly used to deliver medications and fluids to patients with chronic conditions, and as the number of people with these conditions increases, so too will the demand for infusion pumps. New and innovative intravenous infusion pumps that are more accurate, reliable, and user-friendly. These pumps often include features such as wireless connectivity, touchscreen interfaces, and automated monitoring and alerts, which make them easier to use and improve patient safety. As healthcare costs continue to rise and hospitals look for ways to reduce readmissions, there is a growing demand for home healthcare services. Intravenous infusion pumps are an important component of many home healthcare treatments, as they allow patients to receive medication and fluids at home without needing to visit a hospital or clinic. The number of surgical procedures being performed globally is on the rise, driving the demand for intravenous infusion pumps. These pumps are commonly used during surgery to deliver anaesthesia and other medications, and as the number of surgical procedures increases, so too will the demand for infusion pumps. In many countries, healthcare systems provide reimbursement for the use of intravenous infusion pumps, which helps to drive demand for these devices. Reimbursement policies vary by country and by type of infusion pump, but in general, favourable policies are expected to assist the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of intravenous infusion pump. The growth and trends of intravenous infusion pump industry provide a holistic approach to this study.

Market Segmentation:

This section of the intravenous infusion pump market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Enteral Infusion Pumps
• Ambulatory Infusion Pumps
• Patient Controlled Analgesia (PCA)
• Implantable Infusion Pumps
• Others

By Disease Indication

• Chemotherapy
• Diabetes
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics/Neonatology
• Hematology
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Intravenous Infusion Pump market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intravenous infusion pump market include Baxter International, B. Braun Melsungen AG, Medtronic, Micrel Medical Devices SA, Boston Scientific Corporation, CareFusion Corporation, Fresenius Kabi, Smiths Medical, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care Inc., Terumo Corporation, Mindray, Moog Inc., IRadimed Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . INTRAVENOUS INFUSION PUMP - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Disease Indication
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Volumetric Infusion Pumps Historic and Forecast Sales by Regions
• 6.5 Insulin Infusion Pumps Historic and Forecast Sales by Regions
• 6.6 Syringe Infusion Pumps Historic and Forecast Sales by Regions
• 6.7 Enteral Infusion Pumps Historic and Forecast Sales by Regions
• 6.8 Ambulatory Infusion Pumps Historic and Forecast Sales by Regions
• 6.9 Patient Controlled Analgesia (PCA) Historic and Forecast Sales by Regions
• 6.10. Implantable Infusion Pumps Historic and Forecast Sales by Regions
• 6.11 Others Historic and Forecast Sales by Regions

7 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY DISEASE INDICATION

• 7.1 Overview by Disease Indication
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Disease Indication
• 7.4 Chemotherapy Historic and Forecast Sales by Regions
• 7.5 Diabetes Historic and Forecast Sales by Regions
• 7.6 Gastroenterology Historic and Forecast Sales by Regions
• 7.7 Analgesia/Pain Management Historic and Forecast Sales by Regions
• 7.8 Pediatrics/Neonatology Historic and Forecast Sales by Regions
• 7.9 Hematology Historic and Forecast Sales by Regions
• 7.10. Others Historic and Forecast Sales by Regions

8 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE INTRAVENOUS INFUSION PUMP COMPANIES

• 9.1. Intravenous Infusion Pump Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF INTRAVENOUS INFUSION PUMP INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Baxter International
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. B. Braun Melsungen AG
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Medtronic
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Micrel Medical Devices SA
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Boston Scientific Corporation
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. CareFusion Corporation
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Fresenius Kabi
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Smiths Medical
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. F. Hoffmann-La Roche Ltd.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Tandem Diabetes Care Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Terumo Corporation
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments
• 10.14. Mindray
  • 10.14.1. Company Overview
  • 10.14.2. Company Revenue
  • 10.14.3. Products
  • 10.14.4. Recent Developments
• 10.15. Moog Inc.
  • 10.15.1. Company Overview
  • 10.15.2. Company Revenue
  • 10.15.3. Products
  • 10.15.4. Recent Developments
• 10.16. IRadimed Corporation
  • 10.16.1. Company Overview
  • 10.16.2. Company Revenue
  • 10.16.3. Products
  • 10.16.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

•  Market Snapshot
•  Drivers : Impact Analysis
•  Restraints : Impact Analysis
•  List of Raw Material
•  List of Raw Material Manufactures
•  List of Potential Buyers
•  Analysis by Product (USD MN)
•  Volumetric Infusion Pumps Market Sales by Geography (USD MN)
•  Insulin Infusion Pumps Market Sales by Geography (USD MN)
•  Syringe Infusion Pumps Market Sales by Geography (USD MN)
•  Enteral Infusion Pumps Market Sales by Geography (USD MN)
•  Ambulatory Infusion Pumps Market Sales by Geography (USD MN)
•  Patient Controlled Analgesia (PCA) Market Sales by Geography (USD MN)
•  Implantable Infusion Pumps Market Sales by Geography (USD MN)
•  Others Market Sales by Geography (USD MN)
•  Analysis Market by Disease Indication (USD MN)
•  Chemotherapy Market Sales by Geography (USD MN)
•  Diabetes Market Sales by Geography (USD MN)
•  Gastroenterology Market Sales by Geography (USD MN)
•  Analgesia/Pain Management Market Sales by Geography (USD MN)
•  Pediatrics/Neonatology Market Sales by Geography (USD MN)
•  Hematology Market Sales by Geography (USD MN)
•  Others Market Sales by Geography (USD MN)
•  Global Intravenous Infusion Pump Market Sales by Geography (USD MN)
•  North America Market Analysis (USD MN)
•  United State Market Analysis (USD MN)
•  Canada Market Analysis (USD MN)
•  Mexico Market Analysis (USD MN)
•  Europe Market Analysis (USD MN)
•  Europe Market Estimate by Country (USD MN)
•  United Kingdom Market Analysis (USD MN)
•  France Market Analysis (USD MN)
•  Germany Market Analysis (USD MN)
•  Italy Market Analysis (USD MN)
•  Russia Market Analysis (USD MN)
•  Spain Market Analysis (USD MN)
•  Rest of Europe Market Analysis (USD MN)
•  Asia Pacific Market Analysis (USD MN)
•  China Market Analysis (USD MN)
•  Japan Market Analysis (USD MN)
•  India Market Analysis (USD MN)
•  South Korea Market Analysis (USD MN)
•  Australia Market Analysis (USD MN)
•  Rest of Asia Pacific Market Analysis (USD MN)
•  Latin America Market Analysis (USD MN)
•  Brazil Market Analysis (USD MN)
•  Argentina Market Analysis (USD MN)
•  Peru Market Analysis (USD MN)
•  Chile Market Analysis (USD MN)
•  Rest of Latin America Market Analysis (USD MN)
•  Middle East & Africa Market Analysis (USD MN)
•  Saudi Arabia Market Analysis (USD MN)
•  UAE Market Analysis (USD MN)
•  Israel Market Analysis (USD MN)
•  South Africa Market Analysis (USD MN)
•  Rest of Middle East and Africa Market Analysis (USD MN)
•  Partnership/Collaboration/Agreement
•  Mergers And Acquisition

LIST OF FIGURES

•  Research Scope of Intravenous Infusion Pump Report
•  Market Research Process
•  Market Research Methodology
•  Global Intravenous Infusion Pump Market Size, by Region (USD MN)
•  Porters Five Forces Analysis
•  Market Attractiveness Analysis by Product
•  Market Attractiveness Analysis by Disease Indication
•  Market Attractiveness Analysis by Region
•  Value Chain Analysis
•  Global Market Analysis by Product (USD MN)
•  Volumetric Infusion Pumps Market Sales by Geography (USD MN)
•  Insulin Infusion Pumps Market Sales by Geography (USD MN)
•  Syringe Infusion Pumps Market Sales by Geography (USD MN)
•  Enteral Infusion Pumps Market Sales by Geography (USD MN)
•  Ambulatory Infusion Pumps Market Sales by Geography (USD MN)
•  Patient Controlled Analgesia (PCA) Market Sales by Geography (USD MN)
•  Implantable Infusion Pumps Market Sales by Geography (USD MN)
•  Others Market Sales by Geography (USD MN)
•  Global Market Analysis by Disease Indication (USD MN)
•  Chemotherapy Market Sales by Geography (USD MN)
•  Diabetes Market Sales by Geography (USD MN)
•  Gastroenterology Market Sales by Geography (USD MN)
•  Analgesia/Pain Management Market Sales by Geography (USD MN)
•  Pediatrics/Neonatology Market Sales by Geography (USD MN)
•  Hematology Market Sales by Geography (USD MN)
•  Others Market Sales by Geography (USD MN)
•  Global Market by Revenue
•  North America Market by Revenue
•  Europe Market by Revenue
•  Asia Pacific Market by Revenue
•  Latin America Market by Revenue
•  Middle East & Africa Market by Revenue
•  Recent Development in Industry
•  Top Companies Market Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.